# ML_ICI.fast.progression
The R code for Machine Learning Based on Blood Test Biomarkers Predicts Fast Progression in Advanced NSCLC Patients Treated with Immunotherapy


# Machine Learning Based on Blood Test Biomarkers Predicts Fast Progression in Advanced NSCLC Patients Treated with Immunotherapy
Jian-Guo Zhou1,2,3,4*#, Jie Yang5*, Haitao Wang6, Ada Hang-Heng Wong7, Fangya Tan8, Xiaofei Chen9, Si-Si He1, Gang Shen1, Yun-Jia Wang1, Benjamin Frey2,3,4, Rainer Fietkau3,4, Markus Hecht3,4, Wen-Zhao Zhong5#, Hu Ma1# and Udo S. Gaipl2,3,4#

1 Department of Oncology, The second affiliated Hospital of Zunyi Medical University, Zunyi, China
2 Translational Radiobiology, Department of Radiation Oncology, Universitätsklinikum Erlangen, Erlangen, Germany
3 Department of Radiation Oncology, Universitätsklinikum Erlangen, Erlangen, Germany
4 Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany
5 Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
6 Thoracic Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA 
7 AW Medical Company Limited, Macau SAR, China 
8 Department of Analytics, Harrisburg University of Science & Technology, Harrisburg, Pennsylvania, USA
9 Department of Biostat & programming, Sanofi, New Jersey, USA. xiaofei.chen@sanofi.com
* JGZ and JY contributed equally as first authors.
# JGZ, WZZ, HM and USG contributed equally as senior authors.
![image](https://user-images.githubusercontent.com/20199977/202160422-c081ea6a-b878-4f89-b3bb-846a13cc0c4d.png)
